Three MDMA therapy papers retracted over data integrity concerns
The journal Psychopharmacology has retracted three papers about MDMA-assisted psychotherapy — right on the heels of the Food and Drug Administration’s rejection of the closely watched treatment for post-traumatic stress disorder.
Many authors on the three studies are affiliated with the nonprofit Multidisciplinary Association for Psychedelic Studies (MAPS) and its commercial spinout Lykos Therapeutics, including founder Rick Doblin, who spearheaded the decades-long efforts to win approval for the psychedelic treatment. Lykos CEO Amy Emerson is an author as well.
Read Original Article: Three MDMA therapy papers retracted over data integrity concerns »
